| The sensitivity and specificity of Brucella agglutination tests A Mert, R Ozaras, F Tabak, M Bilir, M Yilmaz, C Kurt, S Ongoren, ... Diagnostic Microbiology and infectious disease 46 (4), 241-243, 2003 | 167 | 2003 |
| Overview of 321 patients with idiopathic thrombocytopenic purpura: retrospective analysis of the clinical features and response to therapy G Pamuk, Ö Pamuk, Z Başlar, Ş Öngören, T Soysal, B Ferhanoğlu, ... Annals of hematology 81, 436-440, 2002 | 143 | 2002 |
| T-cell-rich B-cell lymphoma: a clinicopathologic study of 21 cases and comparison with 43 cases of diffuse large B-cell lymphoma H Aki, N Tuzuner, S Ongoren, Z Baslar, T Soysal, B Ferhanoglu, I Sahinler, ... Leukemia research 28 (3), 229-236, 2004 | 66 | 2004 |
| Febril nötropenik hastalarda tanı ve tedavi kılavuzu FNÇ Grubu Flora 9 (1), 5-28, 2004 | 66 | 2004 |
| Bone marrow transplantation for Behçet’s disease: a case report and systematic review of the literature T Soysal, A Salihoğlu, SN Esatoğlu, E Gültürk, AE Eşkazan, G Hatemi, ... Rheumatology 53 (6), 1136-1141, 2014 | 59 | 2014 |
| 17p Deletion is associated with resistance of B-cell chronic lymphocytic leukemia cells to in vitro fludarabine-induced apoptosis B Turgut, O Vural, FS Pala, GE Pamuk, K Tabakcioğlu, M Demir, ... Leukemia & lymphoma 48 (2), 311-320, 2007 | 56 | 2007 |
| Chronic myeloid leukemia patients who develop grade I/II pleural effusion under second-line dasatinib have better responses and outcomes than patients without pleural effusion AE Eskazan, D Eyice, EA Kurt, T Elverdi, FF Yalniz, A Salihoglu, MC Ar, ... Leukemia Research 38 (7), 781-787, 2014 | 40 | 2014 |
| Third-line treatment with second-generation tyrosine kinase inhibitors (dasatinib or nilotinib) in patients with chronic myeloid leukemia after two prior TKIs: real-life data … S Ongoren, AE Eskazan, V Suzan, S Savci, I Erdogan Ozunal, S Berk, ... Hematology 23 (4), 212-220, 2018 | 35 | 2018 |
| Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy AE Eskazan, T Soysal, S Ongoren, E Gulturk, B Ferhanoglu, Y Aydin Haematologica 96 (3), e15, 2011 | 35 | 2011 |
| First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate AE Eskazan, M Ayer, B Kantarcioglu, D Arica, N Demirel, D Aydin, ... British journal of haematology 167 (1), 139-141, 2014 | 30 | 2014 |
| Turkish Chronic Myeloid Leukemia Study: Retrospective Sectional Analysis of CML Patients. F Sahin, G Saydam, M Cömert, B Uz, AS Yavuz, E Turan, İ Yönal, H Atay, ... Turkish Journal of Haematology: Official Journal of Turkish Society of …, 2013 | 29 | 2013 |
| Chronic lymphocytic leukemia in Turkey: experience of a single center in Istanbul ON Pamuk, GE Pamuk, T Soysal, S Ongoren, Z Baslar, B Ferhanoglu, ... Southern medical journal 97 (3), 240-246, 2004 | 29 | 2004 |
| Outcomes of chronic myeloid leukemia patients with early molecular response at 3 and 6 months: a comparative analysis of generic imatinib and glivec AE Eskazan, S Sadri, D Keskin, M Ayer, B Kantarcioglu, N Demirel, ... Clinical Lymphoma Myeloma and Leukemia 17 (12), 804-811, 2017 | 28 | 2017 |
| The efficacy of generic formulations of imatinib mesylate in the treatment of chronic myeloid leukemia AE Eskazan, T Elverdi, FF Yalniz, A Salihoglu, MC Ar, S Ongoren Aydin, ... Leukemia & Lymphoma 55 (12), 2935-2937, 2014 | 27 | 2014 |
| Primary central nervous system lymphoma in immunocompetent individuals: A single center experience H Aki, D Uzunaslan, C Saygin, S Batur, N Tuzuner, A Kafadar, S Ongoren, ... International journal of clinical and experimental pathology 6 (6), 1068, 2013 | 25 | 2013 |
| Secondary infections in febrile neutropenia in hematological malignancies: more than another febrile neutropenic episode A Demirel, F Tabak, MC Ar, B Mete, Ş Öngören, M Yemişen, R Özaras, ... Turkish Journal of Hematology 32 (3), 243, 2015 | 24 | 2015 |
| Primary gastrointestinal diffuse large B cell lymphoma presenting with cold agglutinin disease AE Eskazan, H Akmurad, S Ongoren, O Ozer, B Ferhanoglu Case Reports in Gastroenterology 5 (2), 262-266, 2011 | 22 | 2011 |
| The changing epidemiology of bloodstream infections and resistance in hematopoietic stem cell transplantation recipients M Yemişen, İİ Balkan, A Salihoğlu, AE Eşkazan, B Mete, MC Ar, ... Turkish Journal of Hematology 33 (3), 216, 2016 | 18 | 2016 |
| Essential thrombocythemia and multiple myeloma: two rare diseases in one patient AE Eskazan, S Ongoren, MC Ar, T Soysal, B Ferhanoglu, H Aki, Y Aydin Clinical Lymphoma Myeloma and Leukemia 11 (5), 442-445, 2011 | 17 | 2011 |
| An overview of young CLL patients: a single-centre experience from Turkey. GE Pamuk, ON Pamuk, T Soysal, S Ongören, Z Başlar, B Ferhanoğlu, ... Haematologia 31 (4), 303-311, 2002 | 17 | 2002 |
